JP2001511781A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001511781A5 JP2001511781A5 JP1998533144A JP53314498A JP2001511781A5 JP 2001511781 A5 JP2001511781 A5 JP 2001511781A5 JP 1998533144 A JP1998533144 A JP 1998533144A JP 53314498 A JP53314498 A JP 53314498A JP 2001511781 A5 JP2001511781 A5 JP 2001511781A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9702194.3 | 1997-02-04 | ||
| GBGB9702194.3A GB9702194D0 (en) | 1997-02-04 | 1997-02-04 | Sulphonide derivatives |
| PCT/US1998/001881 WO1998033496A1 (en) | 1997-02-04 | 1998-01-30 | Sulphonamide derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001511781A JP2001511781A (ja) | 2001-08-14 |
| JP2001511781A5 true JP2001511781A5 (https=) | 2005-10-06 |
Family
ID=10807015
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP53314498A Ceased JP2001511781A (ja) | 1997-02-04 | 1998-01-30 | スルホンアミド誘導体 |
Country Status (29)
| Country | Link |
|---|---|
| US (3) | US6303816B1 (https=) |
| EP (2) | EP1528055A2 (https=) |
| JP (1) | JP2001511781A (https=) |
| KR (1) | KR20000070753A (https=) |
| CN (1) | CN1251523A (https=) |
| AR (1) | AR011623A1 (https=) |
| AT (1) | ATE284385T1 (https=) |
| AU (1) | AU760056B2 (https=) |
| BR (1) | BR9807297A (https=) |
| CA (1) | CA2278790A1 (https=) |
| CO (1) | CO5080767A1 (https=) |
| DE (1) | DE69827984T2 (https=) |
| DK (1) | DK0860428T3 (https=) |
| EA (1) | EA001919B1 (https=) |
| ES (1) | ES2232914T3 (https=) |
| GB (1) | GB9702194D0 (https=) |
| HU (1) | HUP0002208A3 (https=) |
| ID (1) | ID22500A (https=) |
| IL (1) | IL130970A (https=) |
| NO (1) | NO993667L (https=) |
| NZ (1) | NZ336559A (https=) |
| PE (1) | PE72899A1 (https=) |
| PL (1) | PL334963A1 (https=) |
| PT (1) | PT860428E (https=) |
| SI (1) | SI0860428T1 (https=) |
| TR (1) | TR199902368T2 (https=) |
| UA (1) | UA71892C2 (https=) |
| WO (1) | WO1998033496A1 (https=) |
| ZA (1) | ZA98842B (https=) |
Families Citing this family (101)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6613804B2 (en) | 1993-05-20 | 2003-09-02 | Encysive Pharmaceuticals, Inc. | Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
| US5877193A (en) * | 1996-07-19 | 1999-03-02 | Hoffmann-La Roche Inc. | Use of N-(4-aryl-thiazol-2-yl)-sulfonamides |
| GB9702194D0 (en) * | 1997-02-04 | 1997-03-26 | Lilly Co Eli | Sulphonide derivatives |
| AP9901643A0 (en) | 1997-04-28 | 1999-10-02 | Texas Biotechnology Corp | Sulfonamides for treatment of endothelin-mediated disorders. |
| FR2763331B1 (fr) * | 1997-05-16 | 1999-06-25 | Rhodia Chimie Sa | Procede de synthese de sulfonimides et de leurs sels |
| AU741742B2 (en) | 1998-02-24 | 2001-12-06 | Eli Lilly And Company | Sulphonamide derivatives |
| PE20000942A1 (es) * | 1998-07-31 | 2000-09-28 | Lilly Co Eli | Derivados de amida, carbamato y urea |
| WO2000006149A1 (en) | 1998-07-31 | 2000-02-10 | Eli Lilly And Company | Sulfonamide derivatives |
| WO2000006176A1 (en) | 1998-07-31 | 2000-02-10 | Eli Lilly And Company | Amidophosphate derivatives |
| ATE266400T1 (de) | 1998-07-31 | 2004-05-15 | Lilly Co Eli | Heterocyclyl sulphonamid derivate |
| US6525099B1 (en) | 1998-07-31 | 2003-02-25 | Eli Lilly And Company | N-substituted sulfonamide derivatives |
| US6358981B1 (en) | 1998-07-31 | 2002-03-19 | Eli Lilly And Company | Sulphonamide derivatives |
| PE20000944A1 (es) * | 1998-07-31 | 2000-09-20 | Lilly Co Eli | Derivados de sulfonamida |
| PE20000943A1 (es) * | 1998-07-31 | 2000-09-28 | Lilly Co Eli | Derivados de sulfonamida |
| AU5235699A (en) | 1998-07-31 | 2000-02-21 | Eli Lilly And Company | Sulfonamide derivatives |
| US6617351B1 (en) | 1998-07-31 | 2003-09-09 | Eli Lilly And Company | Amide, carbamate, and urea derivatives |
| US6693137B1 (en) | 1998-07-31 | 2004-02-17 | Eli Lilly And Company | Sulphonamide derivatives |
| WO2000006539A1 (en) | 1998-07-31 | 2000-02-10 | Eli Lilly And Company | Alkenyl sulphonamide derivatives |
| US6503935B1 (en) | 1998-08-07 | 2003-01-07 | Abbott Laboratories | Imidazoles and related compounds as α1A agonists |
| WO2000066546A2 (en) * | 1999-04-30 | 2000-11-09 | Eli Lilly And Company | Monofluoroalkyl derivatives |
| US6639107B1 (en) | 1999-12-08 | 2003-10-28 | Eli Lilly And Company | Cyclopentyl sulfonamide derivatives |
| WO2001056990A2 (en) * | 2000-02-03 | 2001-08-09 | Eli Lilly And Company | Pyridine derivates as potentiators of glutamate receptors |
| US6911476B2 (en) | 2000-03-13 | 2005-06-28 | Eli Lilly And Company | Sulfonamide derivatives |
| EA004868B1 (ru) | 2000-05-19 | 2004-08-26 | Эли Лилли Энд Компани | Производные сульфонамида |
| US6984756B2 (en) * | 2000-05-19 | 2006-01-10 | Eli Lilly And Company | Process for preparing biphenyl compounds |
| WO2001089510A2 (en) * | 2000-05-24 | 2001-11-29 | Eli Lilly And Company | Use of an ampa receptor potentiator for the treatment of obesity |
| EP1292571A2 (en) * | 2000-06-06 | 2003-03-19 | Eli Lilly And Company | (bis)sulfonamide derivatives |
| JP2004503527A (ja) * | 2000-06-13 | 2004-02-05 | イーライ・リリー・アンド・カンパニー | スルホンアミド誘導体 |
| AU2001284649A1 (en) * | 2000-08-31 | 2002-03-13 | Eli Lilly And Company | Acetylenic sulfonamide derivatives |
| WO2002022579A2 (en) | 2000-09-11 | 2002-03-21 | Sepracor, Inc. | Antipsychotic sulfonamide-heterocycles, and methods of use thereof |
| JP2004511540A (ja) * | 2000-10-13 | 2004-04-15 | イーライ・リリー・アンド・カンパニー | シクロアルキルフルオロスルホンアミド誘導体 |
| AU2002307327A1 (en) * | 2001-05-04 | 2002-11-18 | Eli Lilly And Company | Use of an ampa receptor potentiator for the manufacture of a medicament for the treatment of type 2 diabetes |
| JP2002338538A (ja) * | 2001-05-21 | 2002-11-27 | Takeda Schering-Plough Animal Health Kk | 新規スルホンアミド誘導体およびそれを含む魚類用抗寄生虫薬 |
| WO2002098847A1 (en) * | 2001-05-30 | 2002-12-12 | Eli Lilly And Company | Cycloalkenylsulfonamide derivatives |
| JP2004530708A (ja) * | 2001-06-05 | 2004-10-07 | イーライ・リリー・アンド・カンパニー | スルホンアミド誘導体 |
| US20040235957A1 (en) * | 2001-10-12 | 2004-11-25 | David Bleakman | Use of sulfonamide derivatives as pharmaceuticals compounds |
| US7312214B2 (en) | 2002-05-10 | 2007-12-25 | Bristol-Myers Squibb Company | 1, 1-disubstituted cycloalkyl derivatives as factor Xa inhibitors |
| US7005549B2 (en) * | 2003-01-06 | 2006-02-28 | Hobson David W | Peracid precursors for antimicrobial use |
| US7307191B2 (en) * | 2003-01-06 | 2007-12-11 | Oh Technologies Llp | Organic peroxyacid precursors |
| US7615187B2 (en) * | 2003-01-06 | 2009-11-10 | D H Technologies, LLP | Organic peroxyacid precursors |
| JP2006523707A (ja) * | 2003-04-15 | 2006-10-19 | アストラゼネカ アクツィエボラーグ | 治療化合物 |
| WO2005013961A1 (en) * | 2003-07-17 | 2005-02-17 | Eli Lilly And Company | Combination therapy for treatment of cognitive disorders or psychoses |
| US7625932B2 (en) | 2003-10-08 | 2009-12-01 | Eli Lilly And Company | Pyrrole and pyrazole derivatives as potentiators of glutamate receptors |
| JP2008530162A (ja) * | 2005-02-15 | 2008-08-07 | グラクソ グループ リミテッド | グルタミン酸受容体を増強する化合物および医薬におけるそれらの使用 |
| DE602006003661D1 (de) | 2005-06-06 | 2008-12-24 | Lilly Co Eli | Ampa-rezeptoren-verstärker |
| US7910179B2 (en) * | 2005-11-23 | 2011-03-22 | Lg Chem, Ltd. | Vinylsulfone derivative, liquid crystal composition comprising the same and compensation film using the same liquid crystal composition |
| TW200800150A (en) * | 2005-12-21 | 2008-01-01 | Organon Nv | Compounds with medicinal effects due to interaction with the glucocorticoid receptor |
| WO2007101116A2 (en) * | 2006-02-24 | 2007-09-07 | The Trustees Of Columbia University In The City Of New York | Glur2 receptor modulators |
| US8097652B2 (en) * | 2006-12-11 | 2012-01-17 | Eli Lilly And Company | AMPA receptor potentiators |
| TW200841879A (en) * | 2007-04-27 | 2008-11-01 | Eisai R&D Man Co Ltd | Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same |
| KR101486618B1 (ko) * | 2007-11-01 | 2015-01-26 | 우베 고산 가부시키가이샤 | 설폰산 페닐 화합물, 그것을 사용한 비수 전해액 및 리튬 전지 |
| AR072297A1 (es) | 2008-06-27 | 2010-08-18 | Novartis Ag | Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona. |
| WO2010054336A2 (en) * | 2008-11-10 | 2010-05-14 | The Regents Of The University Of California | Therapeutic uses of ampa receptor modulators for treatment of motor dysfunction |
| EP2316820A1 (en) * | 2009-10-28 | 2011-05-04 | Dompe S.p.A. | 2-aryl-propionamide derivatives useful as bradykinin receptor antagonists and pharmaceutical compositions containing them |
| US20130058915A1 (en) | 2010-03-02 | 2013-03-07 | Children's Medica Center Corporation | Methods and compositions for treatment of angelman syndrome and autism spectrum disorders |
| WO2012074784A2 (en) * | 2010-11-30 | 2012-06-07 | Advanced Neural Dynamics, Inc. | Novel fluorinated sulfamides exhibiting neuroprotective action and their method of use |
| DK2797899T3 (en) * | 2011-12-27 | 2016-04-04 | Bayer Ip Gmbh | Heteroarylpiperidin and -piperazinderivater as fungicides |
| US9073856B2 (en) | 2012-01-23 | 2015-07-07 | Eli Lilly And Company | Phenyl methanesulfonamide derivatives useful as MGAT-2 inhibitors |
| JP5852269B2 (ja) | 2012-01-31 | 2016-02-03 | イーライ リリー アンド カンパニー | Ｍｏｇａｔ−２阻害剤として有用な新規モルホリニル誘導体 |
| WO2013130501A1 (en) * | 2012-03-01 | 2013-09-06 | The Board Of Regents Of The University Of Texas System | Bivalent ampa receptor positive allosteric modulators |
| EP2836482B1 (en) | 2012-04-10 | 2019-12-25 | The Regents of The University of California | Compositions and methods for treating cancer |
| MX2015005739A (es) | 2012-11-06 | 2015-09-16 | Lilly Co Eli | Compuestos novedosos de bencil sulfonamida utiles como inhibidores de mogat-2. |
| UY35464A (es) | 2013-03-15 | 2014-10-31 | Araxes Pharma Llc | Inhibidores covalentes de kras g12c. |
| US9745319B2 (en) | 2013-03-15 | 2017-08-29 | Araxes Pharma Llc | Irreversible covalent inhibitors of the GTPase K-Ras G12C |
| CN103145637A (zh) * | 2013-03-17 | 2013-06-12 | 石家庄学院 | 3-苯基-5-溴-1,2,4-噁二唑衍生物的合成新工艺 |
| EP3008167A4 (en) | 2013-06-13 | 2017-06-07 | VeroScience LLC | Compositions and methods for treating metabolic disorders |
| TWI659021B (zh) | 2013-10-10 | 2019-05-11 | 亞瑞克西斯製藥公司 | Ｋｒａｓ ｇ１２ｃ之抑制劑 |
| JO3556B1 (ar) | 2014-09-18 | 2020-07-05 | Araxes Pharma Llc | علاجات مدمجة لمعالجة السرطان |
| US10011600B2 (en) | 2014-09-25 | 2018-07-03 | Araxes Pharma Llc | Methods and compositions for inhibition of Ras |
| ES2826443T3 (es) | 2014-09-25 | 2021-05-18 | Araxes Pharma Llc | Inhibidores de proteínas mutantes KRAS G12C |
| CN104496920A (zh) * | 2014-12-04 | 2015-04-08 | 北京理工大学 | 一种n-烯丙基-二取代四唑及其制备方法和检测方法 |
| JP2018513853A (ja) | 2015-04-10 | 2018-05-31 | アラクセス ファーマ エルエルシー | 置換キナゾリン化合物およびその使用方法 |
| JP6789239B2 (ja) | 2015-04-15 | 2020-11-25 | アラクセス ファーマ エルエルシー | Ｋｒａｓの縮合三環系インヒビターおよびその使用の方法 |
| US10144724B2 (en) | 2015-07-22 | 2018-12-04 | Araxes Pharma Llc | Substituted quinazoline compounds and methods of use thereof |
| EP3356353A1 (en) | 2015-09-28 | 2018-08-08 | Araxes Pharma LLC | Inhibitors of kras g12c mutant proteins |
| EP3356354A1 (en) | 2015-09-28 | 2018-08-08 | Araxes Pharma LLC | Inhibitors of kras g12c mutant proteins |
| WO2017058902A1 (en) | 2015-09-28 | 2017-04-06 | Araxes Pharma Llc | Inhibitors of kras g12c mutant proteins |
| US10882847B2 (en) | 2015-09-28 | 2021-01-05 | Araxes Pharma Llc | Inhibitors of KRAS G12C mutant proteins |
| US10647703B2 (en) | 2015-09-28 | 2020-05-12 | Araxes Pharma Llc | Inhibitors of KRAS G12C mutant proteins |
| WO2017058807A1 (en) | 2015-09-28 | 2017-04-06 | Araxes Pharma Llc | Inhibitors of kras g12c mutant proteins |
| WO2017058915A1 (en) | 2015-09-28 | 2017-04-06 | Araxes Pharma Llc | Inhibitors of kras g12c mutant proteins |
| JP2018533939A (ja) | 2015-10-19 | 2018-11-22 | アラクセス ファーマ エルエルシー | Ｒａｓの阻害剤をスクリーニングするための方法 |
| KR20180081596A (ko) | 2015-11-16 | 2018-07-16 | 아락세스 파마 엘엘씨 | 치환된 헤테로사이클릭 그룹을 포함하는 2-치환된 퀴나졸린 화합물 및 이의 사용 방법 |
| WO2017100546A1 (en) | 2015-12-09 | 2017-06-15 | Araxes Pharma Llc | Methods for preparation of quinazoline derivatives |
| EP3436021A4 (en) | 2016-03-29 | 2019-11-06 | RespireRx Pharmaceuticals Inc. | COMPOSITIONS AND METHODS FOR TREATING ATTENTION DEFICIT DISORDER |
| WO2017172979A1 (en) | 2016-03-30 | 2017-10-05 | Araxes Pharma Llc | Substituted quinazoline compounds and methods of use |
| US10646488B2 (en) | 2016-07-13 | 2020-05-12 | Araxes Pharma Llc | Conjugates of cereblon binding compounds and G12C mutant KRAS, HRAS or NRAS protein modulating compounds and methods of use thereof |
| US10280172B2 (en) | 2016-09-29 | 2019-05-07 | Araxes Pharma Llc | Inhibitors of KRAS G12C mutant proteins |
| EP3523289A1 (en) | 2016-10-07 | 2019-08-14 | Araxes Pharma LLC | Heterocyclic compounds as inhibitors of ras and methods of use thereof |
| WO2018140513A1 (en) | 2017-01-26 | 2018-08-02 | Araxes Pharma Llc | 1-(3-(6-(3-hydroxynaphthalen-1-yl)benzofuran-2-yl)azetidin-1yl)prop-2-en-1-one derivatives and similar compounds as kras g12c modulators for treating cancer |
| CN110382482A (zh) | 2017-01-26 | 2019-10-25 | 亚瑞克西斯制药公司 | 稠合的杂-杂二环化合物及其使用方法 |
| WO2018140599A1 (en) | 2017-01-26 | 2018-08-02 | Araxes Pharma Llc | Benzothiophene and benzothiazole compounds and methods of use thereof |
| WO2018140514A1 (en) | 2017-01-26 | 2018-08-02 | Araxes Pharma Llc | 1-(6-(3-hydroxynaphthalen-1-yl)quinazolin-2-yl)azetidin-1-yl)prop-2-en-1-one derivatives and similar compounds as kras g12c inhibitors for the treatment of cancer |
| EP3573954A1 (en) | 2017-01-26 | 2019-12-04 | Araxes Pharma LLC | Fused bicyclic benzoheteroaromatic compounds and methods of use thereof |
| US11639346B2 (en) | 2017-05-25 | 2023-05-02 | Araxes Pharma Llc | Quinazoline derivatives as modulators of mutant KRAS, HRAS or NRAS |
| AU2018271990A1 (en) | 2017-05-25 | 2019-12-12 | Araxes Pharma Llc | Covalent inhibitors of KRAS |
| JP2020521741A (ja) | 2017-05-25 | 2020-07-27 | アラクセス ファーマ エルエルシー | がんの処置のための化合物およびその使用の方法 |
| MX2021000887A (es) | 2018-08-01 | 2021-03-31 | Araxes Pharma Llc | Compuestos espiroheterociclicos y metodos de uso de los mismos para el tratamiento de cancer. |
| CN110577512B (zh) * | 2019-09-20 | 2021-01-26 | 河南大学 | 非对称结构5-烷氧基-2,3′-联噻吩及溴代衍生物的制备方法 |
| EP4151616A4 (en) * | 2021-04-26 | 2023-12-20 | Mitsubishi Gas Chemical Company, Inc. | Compound and method for producing same |
| CN114436911B (zh) * | 2022-03-17 | 2023-04-28 | 南京林业大学 | 一种樟脑磺酰苄胺类化合物的制备方法及其应用 |
Family Cites Families (72)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE640160A (https=) | ||||
| US2193015A (en) * | 1939-05-24 | 1940-03-12 | Eastman Kodak Co | Developer containing sulphonamide groups |
| US2548574A (en) * | 1947-02-27 | 1951-04-10 | Eastman Kodak Co | Sulfonamide substituted p-phenylenediamines containing o-alkoxy groups as silver halide photographic developers |
| US2592363A (en) * | 1947-05-23 | 1952-04-08 | Eastman Kodak Co | P-phenylenediamine developer containing nu-alkylacetamido ethyl substituent |
| US2618656A (en) * | 1950-04-29 | 1952-11-18 | Eastman Kodak Co | (alkylsulfonamidoalkyl) arylhydrazines |
| US2652428A (en) * | 1951-05-05 | 1953-09-15 | Eastman Kodak Co | N-alkyl-n-(beta-methylsulfonamidoethyl)-p-aminophenols |
| BE636655A (https=) | 1962-09-14 | |||
| US3147305A (en) | 1962-09-14 | 1964-09-01 | Smith Kline French Lab | 2-phenylcyclopropylsulfamides |
| CH452504A (de) * | 1962-11-20 | 1968-03-15 | Ciba Geigy | Neues Sulfamid |
| DE1240853B (de) | 1962-12-06 | 1967-05-24 | Smith Kline French Lab | Verfahren zur Herstellung von Sulfurylamiden |
| US3257337A (en) | 1962-12-31 | 1966-06-21 | Hooker Chemical Corp | Phosphorus containing polyurethane compositions |
| US3267139A (en) | 1963-09-24 | 1966-08-16 | Smith Kline French Lab | Nu'-trimethylacetyl-nu-phenylalkyl-sulfamides and-phenylcyclopropylsulfamides |
| US3629332A (en) | 1969-01-29 | 1971-12-21 | Minnesota Mining & Mfg | N-(aralkyl)fluoroalkanesulfonamides |
| US3860723A (en) | 1972-02-09 | 1975-01-14 | Smithkline Corp | Methods and compositions for increasing feed intake of animals |
| JPS4929179A (https=) * | 1972-07-07 | 1974-03-15 | ||
| US4210749A (en) | 1974-11-12 | 1980-07-01 | Pennwalt Corporation | Substituted 1,2,4,5-tetrahydro-3H,3 benzazepines |
| JPS6053022B2 (ja) | 1977-04-07 | 1985-11-22 | ウェルファイド株式会社 | ピリダジノン誘導体 |
| DE2809377A1 (de) * | 1978-03-04 | 1979-09-13 | Boehringer Mannheim Gmbh | Phenoxyalkylcarbonsaeure-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel |
| FR2421880A1 (fr) * | 1978-04-06 | 1979-11-02 | Oreal | Nouvelles paraphenylenediamines utilisables en teinture capillaire dite d'oxydation |
| DE3000377A1 (de) * | 1980-01-07 | 1981-07-09 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue sulfonamide, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel |
| US4401663A (en) * | 1981-06-30 | 1983-08-30 | The Procter & Gamble Company | Novel sulfonamide derivatives |
| DE3535167A1 (de) | 1985-10-02 | 1987-04-09 | Boehringer Mannheim Gmbh | Neue sulfonyl-phenyl(alkyl)amine, verfahren zu ihrer herstellung sowie arzneimittel |
| IL83230A (en) | 1986-08-06 | 1992-06-21 | Tanabe Seiyaku Co | Phenoxyacetic acid derivatives,their preparation and pharmaceutical compositions containing them |
| US4863905A (en) * | 1987-02-04 | 1989-09-05 | Warner-Lambert Company | Renin inhibitors II |
| JPH01175962A (ja) | 1987-12-28 | 1989-07-12 | Tanabe Seiyaku Co Ltd | フェニル酢酸誘導体 |
| DE68909958D1 (de) | 1988-01-19 | 1993-11-25 | Tanabe Seiyaku Co | Phenoxyessigsäure-Derivate, ihre Herstellung, pharmazeutische Zusammensetzungen, die sie enthalten, und deren Verwendung. |
| US4971620A (en) | 1988-01-28 | 1990-11-20 | Mitsubishi Kasei Corporation | Sulfonamide and herbicide containing the same as active ingredient |
| DE3821540A1 (de) | 1988-06-25 | 1989-12-28 | Boehringer Mannheim Gmbh | Neue sulfonamide, verfahren zu ihrer herstellung sowie solche sulfonamide enthaltende arzneimittel |
| JPH0272150A (ja) * | 1988-09-06 | 1990-03-12 | Otsuka Pharmaceut Factory Inc | スルホンアミド誘導体 |
| US5160449A (en) | 1989-11-02 | 1992-11-03 | Dow Corning Corporation | Shampoo suspension containing amine functional polydiorganosiloxane |
| JPH0449230A (ja) | 1990-06-19 | 1992-02-18 | Tanabe Seiyaku Co Ltd | トロンボキサンＡ↓ｚ拮抗剤 |
| FR2665440B1 (fr) | 1990-07-31 | 1994-02-04 | Lipha | Nouveaux cycloalkylsulfonamides substitues, procedes de preparation et medicaments les contenant. |
| WO1992008696A1 (en) * | 1990-11-20 | 1992-05-29 | Dunlena Pty. Limited | Herbicides |
| GB9103862D0 (en) * | 1991-02-25 | 1991-04-10 | Glaxo Group Ltd | Chemical compounds |
| AU3361693A (en) * | 1992-01-23 | 1993-09-01 | Smithkline Beecham Plc | Use of 5-HT4 receptor antagonists as medicaments for treating migraine |
| JP4091654B2 (ja) * | 1992-08-25 | 2008-05-28 | ジー．ディー．サール、リミテッド、ライアビリティ、カンパニー | レトロウイルスプロテアーゼ阻害剤として有用なスルホニルアルカノイルアミノヒドロキシエチルアミノスルホンアミド |
| GB9311282D0 (en) | 1993-06-01 | 1993-07-21 | Rhone Poulenc Rorer Ltd | New compositions of matter |
| IL111730A (en) * | 1993-11-29 | 1998-12-06 | Fujisawa Pharmaceutical Co | Piperazine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same |
| DK0657422T3 (da) | 1993-12-09 | 1998-10-12 | Ono Pharmaceutical Co | Naphthyloxyeddikesyrederivater som PEG2-agonister og -antagonister |
| US5483237A (en) | 1994-01-31 | 1996-01-09 | At&T Corp. | Method and apparatus for testing a CODEC |
| HU216747B (hu) * | 1994-05-04 | 1999-08-30 | Novartis Ag. | Fungicid N-szulfonil- és N-szulfinil-aminosav-amidok, ezek előállítása és alkalmazása, valamint ezeket tartalmazó fungicid készítmények |
| AU3414295A (en) | 1994-08-19 | 1996-03-14 | Nps Pharmaceuticals, Inc. | Methods and compounds active at metabotropic glutamate receptors useful for treatment of neurological disorders and diseases |
| KR19980702372A (ko) | 1995-02-21 | 1998-07-15 | 구니이 야쓰오 | 글루타민산 수용체 작용약 |
| MY132385A (en) | 1995-08-31 | 2007-10-31 | Novartis Ag | 2,3-dioxo-1,2,3,4-tetrahydro-quinoxalinyl derivatives |
| US6310095B1 (en) * | 1995-11-06 | 2001-10-30 | University Of Pittsburgh | Inhibitors of protein isoprenyl transferases |
| GB9702194D0 (en) | 1997-02-04 | 1997-03-26 | Lilly Co Eli | Sulphonide derivatives |
| US6174922B1 (en) | 1998-05-11 | 2001-01-16 | Eli Lilly And Company | Sulphonamide derivatives |
| AU5235699A (en) | 1998-07-31 | 2000-02-21 | Eli Lilly And Company | Sulfonamide derivatives |
| WO2000006149A1 (en) | 1998-07-31 | 2000-02-10 | Eli Lilly And Company | Sulfonamide derivatives |
| WO2000006176A1 (en) | 1998-07-31 | 2000-02-10 | Eli Lilly And Company | Amidophosphate derivatives |
| WO2000006539A1 (en) | 1998-07-31 | 2000-02-10 | Eli Lilly And Company | Alkenyl sulphonamide derivatives |
| PE20000942A1 (es) | 1998-07-31 | 2000-09-28 | Lilly Co Eli | Derivados de amida, carbamato y urea |
| PE20000944A1 (es) | 1998-07-31 | 2000-09-20 | Lilly Co Eli | Derivados de sulfonamida |
| PE20000943A1 (es) | 1998-07-31 | 2000-09-28 | Lilly Co Eli | Derivados de sulfonamida |
| US6525099B1 (en) | 1998-07-31 | 2003-02-25 | Eli Lilly And Company | N-substituted sulfonamide derivatives |
| CA2338930A1 (en) | 1998-07-31 | 2000-02-10 | Hamideh Zarrinmayeh | Heterocyclic sulphonamide derivatives |
| US6358981B1 (en) | 1998-07-31 | 2002-03-19 | Eli Lilly And Company | Sulphonamide derivatives |
| ATE266400T1 (de) | 1998-07-31 | 2004-05-15 | Lilly Co Eli | Heterocyclyl sulphonamid derivate |
| WO2000066546A2 (en) | 1999-04-30 | 2000-11-09 | Eli Lilly And Company | Monofluoroalkyl derivatives |
| WO2001042203A1 (en) | 1999-12-08 | 2001-06-14 | Eli Lilly And Company | Cyclopentyl sulfonamide derivatives |
| US6911476B2 (en) | 2000-03-13 | 2005-06-28 | Eli Lilly And Company | Sulfonamide derivatives |
| DE60115444T2 (de) | 2000-05-19 | 2006-07-27 | Eli Lilly And Co., Indianapolis | Verfahren zur herstellung von biphenyl-verbindungen |
| EA004868B1 (ru) | 2000-05-19 | 2004-08-26 | Эли Лилли Энд Компани | Производные сульфонамида |
| JP2003534316A (ja) | 2000-05-19 | 2003-11-18 | イーライ・リリー・アンド・カンパニー | スルホンアミド誘導体 |
| JP2004503527A (ja) | 2000-06-13 | 2004-02-05 | イーライ・リリー・アンド・カンパニー | スルホンアミド誘導体 |
| US20030225127A1 (en) | 2000-08-11 | 2003-12-04 | Bender David Michael | Heterocyclic sulfonamide derivatives |
| EP1313719A2 (en) | 2000-08-11 | 2003-05-28 | Eli Lilly And Company | Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function |
| AU2001284649A1 (en) | 2000-08-31 | 2002-03-13 | Eli Lilly And Company | Acetylenic sulfonamide derivatives |
| JP2004511540A (ja) | 2000-10-13 | 2004-04-15 | イーライ・リリー・アンド・カンパニー | シクロアルキルフルオロスルホンアミド誘導体 |
| US7299729B2 (en) | 2001-05-23 | 2007-11-27 | Cox William A | Rotary die module |
| WO2002098847A1 (en) | 2001-05-30 | 2002-12-12 | Eli Lilly And Company | Cycloalkenylsulfonamide derivatives |
| JP2004530708A (ja) | 2001-06-05 | 2004-10-07 | イーライ・リリー・アンド・カンパニー | スルホンアミド誘導体 |
-
1997
- 1997-02-04 GB GBGB9702194.3A patent/GB9702194D0/en active Pending
- 1997-06-17 US US09/355,605 patent/US6303816B1/en not_active Expired - Lifetime
-
1998
- 1998-01-30 AU AU62595/98A patent/AU760056B2/en not_active Ceased
- 1998-01-30 ID IDW990754A patent/ID22500A/id unknown
- 1998-01-30 WO PCT/US1998/001881 patent/WO1998033496A1/en not_active Ceased
- 1998-01-30 BR BR9807297-8A patent/BR9807297A/pt not_active Application Discontinuation
- 1998-01-30 IL IL13097098A patent/IL130970A/xx not_active IP Right Cessation
- 1998-01-30 JP JP53314498A patent/JP2001511781A/ja not_active Ceased
- 1998-01-30 HU HU0002208A patent/HUP0002208A3/hu unknown
- 1998-01-30 KR KR1019997007012A patent/KR20000070753A/ko not_active Ceased
- 1998-01-30 CN CN98803753A patent/CN1251523A/zh active Pending
- 1998-01-30 PL PL98334963A patent/PL334963A1/xx not_active Application Discontinuation
- 1998-01-30 NZ NZ336559A patent/NZ336559A/xx unknown
- 1998-01-30 UA UA99084464A patent/UA71892C2/uk unknown
- 1998-01-30 CA CA002278790A patent/CA2278790A1/en not_active Abandoned
- 1998-01-30 TR TR1999/02368T patent/TR199902368T2/xx unknown
- 1998-01-30 EA EA199900719A patent/EA001919B1/ru not_active IP Right Cessation
- 1998-02-02 ZA ZA9800842A patent/ZA98842B/xx unknown
- 1998-02-02 CO CO98004892A patent/CO5080767A1/es unknown
- 1998-02-03 DK DK98300759T patent/DK0860428T3/da active
- 1998-02-03 ES ES98300759T patent/ES2232914T3/es not_active Expired - Lifetime
- 1998-02-03 PT PT98300759T patent/PT860428E/pt unknown
- 1998-02-03 EP EP04104929A patent/EP1528055A2/en not_active Withdrawn
- 1998-02-03 DE DE69827984T patent/DE69827984T2/de not_active Expired - Lifetime
- 1998-02-03 EP EP98300759A patent/EP0860428B1/en not_active Expired - Lifetime
- 1998-02-03 SI SI9830743T patent/SI0860428T1/xx unknown
- 1998-02-03 AT AT98300759T patent/ATE284385T1/de not_active IP Right Cessation
- 1998-02-04 AR ARP980100477A patent/AR011623A1/es unknown
- 1998-02-04 PE PE1998000078A patent/PE72899A1/es not_active Application Discontinuation
-
1999
- 1999-07-28 NO NO993667A patent/NO993667L/no not_active Application Discontinuation
-
2001
- 2001-07-25 US US09/912,809 patent/US6596716B2/en not_active Expired - Fee Related
-
2003
- 2003-05-29 US US10/447,619 patent/US7135487B2/en not_active Expired - Fee Related